


Amwins Releases State of the Market Report: A Focus on Healthcare
Amwins, a global distributor specializing in insurance products and services, released on November 8 a healthcare-focused State of the Market report. The report offers insights into current market trends, their impact on capacity and pricing and the specific challenges faced by different classes within the healthcare industry. The Amwins Healthcare State of the Market Report delves into the multitude of factors influencing the healthcare marketplace. It includes detailed insights across critical segments, such as long-term care and senior living facilities, hospitals and non-emergency medical transport (NEMT). “Current developments are keeping the trajectory of the... Read More »
CVS Health Scores with $2.2 Billion in Q3 Profit Amid Layoffs and Acquisitions
CVS Health (NYSE: CVS) released its Q3:23 operating results on Wednesday, November 1, 2023. The company reported net income of $2.2 billion, or $1.75 per share, thanks to double-digit percentage sales growth across all the company’s businesses and contributions from its new healthcare services acquisitions. This compares to the net loss of $3.4 billion, or $2.59 per share, announced in the same quarter last year when the company recorded $5 billion in opioid-related litigation charges. The giant drugstore chain has spent nearly $20 billion this year on acquisitions. First, the company added senior primary care centers via its acquisition of Oak Street Health for $10.6 billion in February.... Read More »
Telemedicine Surge Drives Increased EHR Utilization, New Study From JAMA Reveals
In a recently published report in JAMA Internal Medicine, A. Jay Holmgren, PhD, and colleagues explore the relationship between the increasing adoption of telemedicine and key indicators of electronic health record (EHR) utilization among ambulatory physicians. Over a period of 115 weeks, the study observed 1,052 ambulatory physicians at a major academic medical center, providing a robust dataset of 35,697 physician-week observations. The aim of the study was to investigate how telemedicine utilization influenced physician EHR engagement and patient messaging volume in the ambulatory healthcare setting. There has been an increase in telehealth M&A this year. While most eHealth... Read More »
Danaher Disappoints with Q3:23 Sales and Profit Decline
Danaher Corp. (NYSE: DHR), a well-known player in the medical device market, recently unveiled its third-quarter financial results on October 24. With a global presence, Danaher specializes in the design, manufacture and distribution of professional, medical, industrial and commercial products and services. The latest earnings report painted a somber picture for Danaher, as the company grappled with a decline in both sales and profits compared to the previous year. This underwhelming performance came as the pharma and biotech sectors experienced a broader loss of momentum in critical markets. “Pharma and biotech took a modest step down, and that was particularly the case in the U.S. In... Read More »